Skip to main content
logo
INBIOGEN Co., Ltd. (KRX:101140)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,890.00
+90.00 (1.02%)
At close: Apr 24, 2026

INBIOGEN Revenue

In the year 2025, INBIOGEN had annual revenue of 6.30B KRW, down -10.57%. INBIOGEN had revenue of 660.60M in the quarter ending December 31, 2025, a decrease of -69.52%.

Revenue
6.30B
Revenue Growth
-10.57%
P/S Ratio
14.10
Revenue / Employee
153.58M
Employees
41
Market Cap
88.76B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20256.30B-744.31M-10.57%
Dec 31, 20247.04B800.26M12.82%
Dec 31, 20236.24B-4.18B-40.10%
Dec 31, 202210.42B-61.30M-0.58%
Dec 31, 202110.48B263.11M2.58%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
HWASEUNG Industries1.78T
Hwaseung Enterprise1.56T
JS Corporation1.29T
BAIKSAN Co,.504.92B
The Nature Holdings477.52B
Samyang Tongsang174.69B
Uni-Chem106.24B
Au Brandz Co.,Ltd60.01B
Revenue Rankings

INBIOGEN News

More News